Advertisement

Morphine Injections

[25 August 2016]

Products Affected - Description

Morphine injection, BD Rx
8 mg/mL, 1 mL preservative-free prefilled syringe, 24 count (NDC 76045-0007-10)
 
Morphine injection, Hospira
2 mg/mL, 1 mL preservative-free iSecure syringe, 10 count (NDC 00409-1890-11)
15 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count (NDC 00409-1894-01) - discontinued
5 mg/mL, 4 mL ADD-Vantage vial, 50 count (NDC 00409-6177-14)
25 mg/mL, 10 mL ADD-Vantage vial, 50 count (NDC 00409-6179-14)
 
Morphine injection, West-Ward
8 mg/mL, 1 mL vial, 25 count (NDC 00641-6075-25)

Reason for the Shortage

  • Astramorph injection has been unavailable since 2012. Fresenius Kabi changed manufacturing sites and cannot estimate if Astramorph will return.
  • Hospira states the shortage is due to manufacturing delays.
  • West-Ward launched several new morphine sulfate products in late-September 2015. They are not actively marketing the 15 mg/mL 1mL vials.

Available Products

Duramorph (preservative-free) injection, West-Ward
0.5 mg/mL, 10 mL ampule, 10 count (NDC 00641-6020-10)
1 mg/mL, 10 mL ampule, 10 count (NDC 00641-6019-10)
 
Infumorph (preservative-free), West-Ward
10 mg/mL, 20 mL ampule, 1 count (NDC 00641-6039-01)
25 mg/mL, 20 mL ampule, 1 count (NDC 00641-6040-01)
 
Morphine Injection, BD Rx
2 mg/mL, 1 mL preservative-free syringe, 24 count (NDC 76045-0004-10)
4 mg/mL, 1 mL preservative-free syringe, 24 count (NDC 76045-0005-10)
5 mg/mL, 1 mL preservative-free syringe, 24 count (NDC 76045-0006-10)
10 mg/mL, 1 mL preservative-free syringe, 24 count (NDC 76045-0008-10)
 
Morphine Injection, Hospira
0.5 mg/mL, 10 mL preservative-free vial, 25 count (NDC 00409-3814-12)
1 mg/mL, 10 mL preservative-free vial, 25 count (NDC 00409-3815-12)
2 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count (NDC 00409-1890-01)
4 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count (NDC 00409-1891-01)
4 mg/mL, 1 mL preservative-free iSecure syringe, 10 count (NDC 00409-1891-11)
8 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count(NDC 00409-1892-01)
8 mg/mL, 1 mL preservative-free iSecure syringe, 10 count (NDC 00409-1892-11)
10 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count (NDC 00409-1893-01)
10 mg/mL, 1 mL preservative-free iSecure syringe, 10 count (NDC 00409-1893-11)
25 mg/mL, 1 mL preservative-free vial, 50 count (NDC 00409-1135-02)
50 mg/mL, 20 mL vial, 50 count (NDC 00409-1134-03)
50 mg/mL, 50 mL vial, 50 count, NDC 00409-1134-05)
 
Morphine injection, West-Ward
4 mg/mL, 1 mL vial, 25 count (NDC 00641-6125-25)
8 mg/mL, 1 mL vial, 25 count (NDC 00641-6126-25)
10 mg/mL, 1 mL vial, 25 count (NDC 00641-6127-25)

Estimated Resupply Dates

  • Hospira has morphine 2 mg/mL 1 mL iSecure syringes on back order and the company estimates a release date of late-August 2016. Morphine 25 mg/mL 4 mL and 10 mL ADD-Vantage vials are on back order and the company cannot estimate a release date.
  • West-Ward has 8 mg/mL 1 mL vials (NDC 00641-6075-25) on back order and the company cannot estimate a release date..
  • BD Rx has morphine 8 mg/mL 1 mL syringes on back order and the company estimates a release date in early-October 2016.

Related Shortages

Updated

August 25 and 1, June 23, May 25, April 11, February 24, January 29, 2016; December 17, November 17, October 19, September 30, July 14, May 11, March 31, February 20, 2015; December 22, November 14, October 31, September 23, August 29, July 30, June 12, May 19, April 23, March 31, February 14, 2014; December 10, November 1, October 11, September 3, August 14, July 12, June 19, April 25, February 6, January 23, 2013; December 12, November 30, September 26, August 31, June 15, May 25, April 20, March 21, February 23, January 24, 2012; December 22, November 21, October 19, September 1, August 19, July 28, June 23, May 5, March 24, February 15, January 6, 2011; December 2, November 17, October 28, September 28, August 30, July 16, June 24, May 19, 2010; December 2, November 11, October 21, September 16, June 23, 2009, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing